Skip to main content Accessibility help

The impact of periventricular white matter lesions in patients with bipolar disorder type I

  • Gianluca Serafini (a1), Maurizio Pompili (a1), Marco Innamorati (a1), Nicoletta Girardi (a2), Leonardo Strusi (a3), Mario Amore (a4), Leo Sher (a5), Xenia Gonda (a6) (a7) (a8) (a9), Zoltan Rihmer (a6) (a9) and Paolo Girardi (a1)...



White matter hyperintensities (WMHs) are one the most common neuroimaging findings in patients with bipolar disorder (BD). It has been suggested that WMHs are associated with impaired insight in schizophrenia and schizoaffective patients; however, the relationship between insight and WMHs in BD type I has not been directly investigated.


Patients with BD-I (148) were recruited and underwent brain magnetic resonance imaging (MRI). Affective symptoms were assessed using Young Mania Rating Scale (YMRS) and Hamilton Depression Rating Scale (HDRS17); the presence of impaired insight was based on the corresponding items of YMRS and HDRS17.


Multiple punctate periventricular WMHs (PWMHs) and deep WMHs (DWMHs) were observed in 49.3% and 39.9% of the cases, respectively. Subjects with lower insight for mania had significantly more PWMHs (54.6% vs 22.2%; p < 0.05) when compared to BD-I patients with higher insight for mania. The presence of PWMHs was independently associated with lower insight for mania: patients who denied illness according to the YMRS were 4 times more likely to have PWMHs (95% CI: 1.21/13.42) than other patients.


Impaired insight in BD-I is associated with periventricular WMHs. The early identification of BD-I subjects with PWMHs and impaired insight may be crucial for clinicians.


Corresponding author

*Address for correspondence: Gianluca Serafini, MD, PhD, Department of Neurosciences, Mental Health and Sensory Organs, Sant'Andrea Hospital, Sapienza University of Rome, 1035-1039 Via di Grottarossa, 00189, Rome, Italy. (Email


Hide All

Xenia Gonda is recipient of the János Bolyai Research Fellowship of Hungarian Academy of Sciences.



Hide All
1. Thomas, AJ, Perry, R, Barber, R, Kalaria, RR, O'Brien, JT. Pathologies and pathological mechanisms for white matter hyperintensities in depression. Ann N Y Acad Sci. 2002; 977: 333339.
2. Thomas, AJ, O'Brien, JT, Davis, S, etal. Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry. 2002; 59(9): 785792.
3. Ovbiagele, B, Saver, JL. Cerebral white matter hyperintensities on MRI: current concepts and therapeutic implications. Cerebrovasc Dis. 2006; 22(2–3): 8390.
4. Steffens, DC, Krishnan, KR. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry. 1998; 43(10): 705712.
5. Videbech, P. MRI findings in patients with affective disorder: a metaanalysis. Acta Psychiatr Scand. 1997; 96(3): 157168.
6. Ehrlich, S, Noam, GG, Lyoo, IK, etal. White matter hyperintensities and their associations with suicidality in psychiatrically hospitalized children and adolescents. J Am Acad Child Adolesc Psychiatry. 2004; 43(6): 770776.
7. Ehrlich, S, Breeze, JL, Hesdorffer, DC, etal. White matter hyperintensities and their association with suicidality in depressed young adults. J Affect Disord. 2005; 86(2–3): 281287.
8. Pompili, M, Ehrlich, S, De Pisa, E, etal. White matter hyperintensities and their associations with suicidality in patients with major affective disorders. Eur Arch Psychiatry Clin Neurosci. 2007; 257(8): 494499.
9. Soares, JC, Mann, JJ. The anatomy of mood disorders—review of structural neuroimaging studies. Biol Psychiatry. 1997; 41(1): 86106.
10. Taylor, WD, Payne, ME, Krishnan, KR, etal. Evidence of white matter tract disruption in MRI hyperintensities. Biol Psychiatry. 2001; 50(3): 179183.
11. Ishak, WW, Brown, K, Aye, SS, etal. Health-related quality of life in bipolar disorder. Bipolar Disord. 2012; 14(1): 618.
12. Schneider, MR, DelBello, MP, McNamara, RK, Strakowski, SM, Adler, CM. Neuroprogression in bipolar disorder. Bipolar Disord. 2012; 14(4): 356374.
13. Beyer, JL Krishnan, KR. Volumetric brain imaging findings in mood disorders. Bipolar Disord. 2002; 4(2): 89104.
14. Singh, MK, Chang, KD, Chen, MC, etal. Volumetric reductions in the subgenual anterior cingulate cortex in adolescents with bipolar I disorder. Bipolar Disord. 2012; 14(6): 585596.
15. Baloch, HA, Hatch, JP, Olvera, RL, etal. Morphology of the subgenual prefrontal cortex in pediatric bipolar disorder. J Psychiatr Res. 2010; 44(15): 11061110.
16. Tighe, SK, Reading, SA, Rivkin, P, etal. Total white matter hyperintensity volume in bipolar disorder patients and their healthy relatives. Bipolar Disord. 2012; 14(8): 888893.
17. Serafini, G, Pompili, M, Innamorati, M, etal. White matter hyperintensities and self-reported depression in a sample of patients with chronic headache. J Headache Pain. 2012; 13(8): 661667.
18. Oudega, ML, van Exel, E, Wattjes, MP, etal. White matter hyperintensities, medial temporal lobe atrophy, cortical atrophy, and response to electroconvulsive therapy in severely depressed elderly patients. J Clin Psychiatry. 2011; 72(1): 104112.
19. Serafini, G, Pompili, M, Innamorati, M, etal. Affective temperamental profiles are associated with white matter hyperintensity and suicidal risk in patients with mood disorders. J Affect Disord. 2011; 129(1–3): 4755.
20. Serafini, G, Pompili, M, Innamorati, M, etal. Deep white matter hyperintensities as possible predictor of poor prognosis in a sample of patients with late-onset bipolar II disorder. Bipolar Disord. 2010; 12(7): 755766.
21. Gunning-Dixon, FM, Walton, M, Cheng, J, etal. MRI signal hyperintensities and treatment remission of geriatric depression. J Affect Disord. 2010; 126(3): 395401.
22. Köhler, S, Thomas, AJ, Lloyd, A, etal. White matter hyperintensities, cortisol levels, brain atrophy and continuing cognitive deficits in late-life depression. Br J Psychiatry. 2010; 196(2): 143149.
23. Bae, S, Kim, JE, Hwang, J, etal. Increased prevalence of white matter hyperintensities in patients with panic disorder. J Psychopharmacol. 2010; 24(5): 717723.
24. Fein, G, Shimotsu, R, Di Sclafani, V, Barakos, J, Harper, C. Increased white matter signal hyperintensities in long-term abstinent alcoholics compared with nonalcoholic controls. Alcohol Clin Exp Res. 2009; 33(1): 7078.
25. Pompili, M, Innamorati, M, Mann, JJ, etal. Periventricular white matter hyperintensities as predictors of suicide attempts in bipolar disorders and unipolar depression. Prog Neuropsychopharmacol Biol Psychiatry. 2008; 32(6): 15011507.
26. Sheline, YI, Price, JL, Vaishnavi, SN, etal. Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors. Am J Psychiatry. 2008; 165(4): 524532.
27. Regenold, WT, Hisley, KC, Phatak, P, etal. Relationship of cerebrospinal fluid glucose metabolites to MRI deep white matter hyperintensities and treatment resistance in bipolar disorder patients. Bipolar Disord. 2008; 10(7): 753764.
28. Takahashi, K, Oshima, A, Ida, I, etal. Relationship between age at onset and magnetic resonance image-defined hyperintensities in mood disorders. J Psychiatr Res. 2008; 42(6): 443450.
29. Zanetti, MV, Schaufelberger, MS, de Castro, CC, etal. White-matter hyperintensities in first-episode psychosis. Br J Psychiatry. 2008; 193(1): 2530.
30. Iosifescu, DV, Renshaw, PF, Dougherty, DD, etal. Major depressive disorder with anger attacks and subcortical MRI white matter hyperintensities. J Nerv Ment Dis. 2007; 195(2): 175178.
31. Patankar, TF, Baldwin, R, Mitra, D, etal. Virchow-Robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression. J Affect Disord. 2007; 97(1–3): 265270.
32. Bae, SC, Lyoo, IK, Sung, YH, etal. Increased white matter hyperintensitiesin male methamphetamine abusers. Drug Alcohol Depend. 2006; 81(1): 8388.
33. Iosifescu, DV, Renshaw, PF, Lyoo, IK, etal. Brain white-matter hyperintensities and treatment outcome in major depressive disorder. Br J Psychiatry. 2006; 188: 180185.
34. Anstey, KJ, Jorm, AF, Réglade-Meslin, C, etal. Weekly alcohol consumption, brain atrophy, and white matter hyperintensities in a community-based sample aged 60 to 64 years. Psychosom Med. 2006; 68(5): 778785.
35. Jorm, AF, Anstey, KJ, Christensen, H, etal. MRI hyperintensities and depressive symptoms in a community sample of individuals 60-64 years old. Am J Psychiatry. 2005; 162(4): 699705.
36. Lin, HF, Kuo, YT, Chiang, IC, Chen, HM, Chen, CS. Structural abnormality on brain magnetic resonance imaging in late-onset major depressive disorder. Kaohsiung J Med Sci. 2005; 21(9): 405411.
37. Hickie, I, Naismith, S, Ward, PB, etal. Vascular risk and low serum B12 predict white matter lesions in patients with major depression. J Affect Disord. 2005; 85(3): 327332.
38. Heiden, A, Kettenbach, J, Fischer, P, etal. White matter hyperintensities and chronicity of depression. J Psychiatr Res. 2005; 39(3): 285293.
39. Lyoo, IK, Streeter, CC, Ahn, KH, etal. White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects. Psychiatry Res. 2004; 131(2): 135145.
40. Firbank, MJ, Lloyd, AJ, Ferrier, N, O'Brien, JT. A volumetric study of MRI signal hyperintensitiesin late-life depression. Am J Geriatr Psychiatry. 2004; 12(6): 606612.
41. Taylor, WD, Steffens, DC, MacFall, JR, etal. White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatry. 2003; 60(11): 10901096.
42. Breeze, JL, Hesdorffer, DC, Hong, X, Frazier, JA, Renshaw, PF. Clinical significance of brain white matter hyperintensities in young adults with psychiatric illness. Harv Rev Psychiatry. 2003; 11(5): 269283.
43. Agid, R, Levin, T, Gomori, JM, Lerer, B, Bonne, O. T2-weighted image hyperintensities in major depression: focus on the basal ganglia. Int J Neuropsychopharmacol. 2003; 6(3): 215224.
44. Taylor, WD, MacFall, JR, Steffens, DC, Payne, ME, Provenzale, JM, Krishnan, KR. Localization of age-associated white matter hyperintensities in late-life depression. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27(3): 539544.
45. Silverstone, T, McPherson, H, Li, Q, Doyle, T. Deep white matter hyperintensities in patients with bipolar depression, unipolar depression and age-matched control subjects. Bipolar Disord. 2003; 5(1): 5357.
46. Pillai, JJ, Friedman, L, Stuve, TA, etal. Increased presence of white matter hyperintensities in adolescent patients with bipolar disorder. Psychiatry Res. 2002; 114(1): 5156.
47. Ahearn, EP, Jamison, KR, Steffens, DC, etal. MRI correlates of suicide attempt history in unipolar depression. Biol Psychiatry. 2001; 50(4): 266270.
48. Rivkin, P, Kraut, M, Barta, P, etal. White matter hyperintensity volume in late-onset and early-onset schizophrenia. Int J Geriatr Psychiatry. 2000; 15(12): 10851089.
49. Sachdev, P, Brodaty, H, Rose, N, Cathcart, S. Schizophrenia with onset after age 50 years. 2: Neurological, neuropsychological and MRI investigation. Br J Psychiatry. 1999; 175: 416421.
50. Sachdev, P, Brodaty, H. Quantitative study of signal hyperintensities on T2-weighted magnetic resonance imaging in late-onset schizophrenia. Am J Psychiatry. 1999; 156(12): 19581967.
51. Symonds, LL, Olichney, JM, Jernigan, TL, etal. Lack of clinically significant gross structural abnormalities in MRIs of older patients with schizophrenia and related psychoses. J Neuropsychiatry Clin Neurosci. 1997; 9(2): 251258.
52. Vasudev, A, Thomas, A. ‘Bipolar disorder’ in the elderly: what's in a name? Maturitas. 2010; 66(3): 231235.
53. Altshuler, LL, Curran, JG, Hauser, P, etal. T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis. Am J Psychiatry. 1995; 152(8): 11391144.
54. Vieta, E, Suppes, T. Bipolar II disorder: arguments for and against a distinct diagnostic entity. Bipolar Disord. 2008; 10(1 Pt 2): 163178.
55. Moore, PB, Shepherd, DJ, Eccleston, D, etal. Cerebral white matter lesions in bipolar affective disorder: relationship to outcome. Br J Psychiatry. 2001; 178: 172176.
56. Cassidy, F. Insight in bipolar disorder: relationship to episode subtypes and symptom dimensions. Neuropsychiatr Dis Treat. 2010; 6(1): 627631.
57. Van Der Werf-Eldering, MJ, Van Der Meer, L, Burger, H, etal. Insight in bipolar disorder: associations with cognitive and emotional processing and illness characteristics. Bipolar Disord. 2011; 13(4): 343354.
58. Antonius, D, Prudent, V, Rebani, Y, etal. White matter integrity and lack of insight in schizophrenia and schizoaffective disorder. Schizophr Res. 2011; 128(1–3): 7682.
59. Bassitt, DP, Neto, MR, De Castro, CC, Busatto, GF. Insight and regional brain volumes in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2007; 257(1): 5862.
60. Palaniyappan, L, Mallikarjun, P, Joseph, V, Liddle, PF. Appreciating symptoms and deficits in schizophrenia: right posterior insula and poor insight. Prog Neuropsychopharmacol Biol Psychiatry. 2011; 35(2): 523527.
61. Rossell, SL, Coakes, J, Shapleske, J, Woodruff, PW, David, AS. Insight: its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychol Med. 2003; 33(1): 111119.
62. Serafini, G, Pompili, M, Innamorati, M, etal. Gene variants with suicidal risk in a sample of subjects with chronic migraine and affective temperamental dysregulation. Eur Rev Med Pharmacol Sci. 2012; 16(10): 13891398.
63. Pompili, M, Serafini, G, Innamorati, M, etal. White matter hyperintensities, suicide risk and late-onset affective disorders: an overview of the current literature. Clin Ter. 2010; 161(6): 555563.
64. Serafini, G, Pompili, M, Innamorati, M, etal. Affective temperamental profiles are associated with white matter hyperintensity and suicidal risk in patients with mood disorders. J Affect Disord. 2011; 129(1–3): 4755.
65. Pompili, M, Rihmer, Z, Akiskal, HS, etal. Temperament and personality dimensions in suicidal and nonsuicidal psychiatric inpatients. Psychopathology. 2008; 41(5): 313321.
66. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text rev. Washington, DC: American Psychiatric Association; 1994.
67. Young, RC, Biggs, JT, Ziegler, VE, Meyer, DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978; 133(5): 429435.
68. Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23(1): 5662.
69. Sheehan, DV, Lecrubier, Y, Sheehan, KH, etal. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSMIV and ICD-10. J Clin Psychiatry. 1998; 59(Suppl 20): 2233; quiz 34–57.
70. Beck, AT, Weissman, A, Lester, D, Trexler, L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol. 1974; 42(6): 861865.
71. Beck, AT, Steer, RA. Clinical predictors of eventual suicide: a 5- to 10- year prospective study of suicide attempters. J Affect Disord. 1989; 17(3): 203209.
72. Coffey, CE, Wilkinson, WE, Weiner, RD, etal. Quantitative cerebral anatomy in depression: a controlled magnetic resonance imaging study. Arch Gen Psychiatry. 1993; 50(1): 716.
73. Amorim, P, Lecrubier, Y, Weiller, E, Hergueta, T, Sheehan, D. DSM-IH-R psychotic disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI. Eur Psychiatry. 1998; 13(1): 2634.
74. Beck, AT, Brown, G, Berchick, RJ, Stewart, BL, Steer, RA. Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiatry. 1990; 147(2): 190195.
75. Beck, AT, Steer, RA, Kovacs, M, Garrison, B. Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry. 1985; 142(5): 559563.
76. Craig, AD. Interoception: the sense of the physiological condition of the body. Curr Opin Neurobiol. 2003; 13(4): 500505.
77. Figiel, GS, Krishnan, KR, Doraiswamy, PM, Nemeroff, CB. Caudate hyperintensities in elderly depressed patients with neuroleptic-induced parkinsonism. J Geriatr Psychiatry Neurol. 1991; 4(2): 8689.
78. Greenwald, BS, Kramer-Ginsberg, E, Krishnan, KR, etal. Neuroanatomic localization of magnetic resonance imaging signal hyperintensities in geriatric depression. Stroke. 1998; 29(3): 613617.
79. Hwang, J, Lyoo, lk, Dager, SR, etal. Basal ganglia shape alterations in bipolar disorder. Am J Psychiatry. 2006; 163(2): 276285.
80. Steffens, DC, Helms, MJ, Krishnan, KR, Burke, GL. Cerebrovascular disease and depression symptoms in the cardiovascular health study. Stroke. 1999; 30(10): 21592166.
81. Strakowski, SM, Delbello, MP, Adler, C, Cecil, DM, Sax, KW. Neuroimaging in bipolar disorder. Bipolar Disord. 2000; 2(3 Pt 1): 148164.
82. Taylor, WD, Macfall, JR, Steffens, DC, etal. Localization of age-associated white matter hyperintensities in late-life depression. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27(3): 539544.
83. DeCarli, C, Murphy, DG, Tranh, M, etal. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology. 1995; 45(11): 20772084.
84. Berthier, ML, Kulisevsky, J, Gironell, A, Fernández Benitez, JA. Poststroke bipolar affective disorder: clinical subtypes, concurrent movement disorders, and anatomical correlates. J Neuropsychiatry Clin Neurosci. 1996; 8(2): 160167.
85. Celik, Y, Erdogan, E, Tuglu, C, Utku, U. Post-stroke mania in late life due to right temporoparietal infarction. Psychiatry Clin Neurosci. 2004; 58(4): 446447.
86. Kilbourne, AM. The burden of general medical conditions in patients with bipolar disorder. Curr Psychiatry Rep. 2005; 7(6): 471477.
87. Yates, WR, Wallace, R. Cardiovascular risk factors in affective disorder. J Affect Disord. 1987; 12(2): 129134.
88. Liu, J, Blond, BN, van Dyck, LI, etal. Trait and state corticostriatal dysfunction in bipolar disorder during emotional face processing. Bipolar Disord. 2012; 14(4): 432441.
89. Van der Schot, A, Kahn, R, Ramsey, N, Nolen, W, Vink, M. Trait and state dependent functional impairments in bipolar disorder. Psychiatry Res. 2010; 184(3): 135142.
90. Shad, MU, Muddasani, S, Prasad, K, Sweeney, JA, Keshavan, MS. Insight and prefrontal cortex in first-episode schizophrenia. Neuroimage. 2004; 22(3): 13151320.
91. Ha, TH, Youn, T, Ha, KS, etal. Gray matter abnormalities in paranoid schizophrenia and their clinical correlations. Psychiatry Res. 2004; 132(3): 251260.
92. David, AS, Buchanan, A, Reed, A, Almeida, O. The assessment of insight in psychosis. Br J Psychiatry. 1992; 161: 599602.
93. Birchwood, M, Smith, J, Drury, V, etal. A self-report insight scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatr Scand. 1994; 89(1): 6267.
94. Cuesta, MJ, Peralta, V, Zarzuela, A. Reappraising insight in psychosis: multi-scale longitudinal study. Br J Psychiatry. 2000; 177(3): 233240.
95. Drake, RJ, Lewis, SW. Insight and neurocognition in schizophrenia. Schizophr Res. 2003; 62(1–2): 165173.
96. Lincoln, TM, Lüllmann, E, Rief, W. Correlates and long-term consequences of poor insight in patients with schizophrenia: a systematic review. Schizophr Bull. 2007; 33(6): 13241342.
97. Sanz, M, Constable, G, Lopez-Ibor, I, Kemp, R, David, AS. A comparative study of insight scales and their relationship to psychopathological and clinical variables. Psychol Med. 1998; 28(2): 437446.
98. Sassi, RB, Brambilla, P, Nicoletti, M, etal. White matter hyperintensities in bipolar and unipolar patients with relatively mild-to-moderate illness severity. J Affect Disord. 2003; 77(3): 237245.
99. Persaud, R, Russow, H, Harvey, I, etal. Focal signal hyperintensities in schizophrenia. Schizophr Res. 1997; 27(1): 5564.


Related content

Powered by UNSILO

The impact of periventricular white matter lesions in patients with bipolar disorder type I

  • Gianluca Serafini (a1), Maurizio Pompili (a1), Marco Innamorati (a1), Nicoletta Girardi (a2), Leonardo Strusi (a3), Mario Amore (a4), Leo Sher (a5), Xenia Gonda (a6) (a7) (a8) (a9), Zoltan Rihmer (a6) (a9) and Paolo Girardi (a1)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.